BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36238647)

  • 21. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.
    Gan W; Huang JL; Zhang MX; Fu YP; Yi Y; Jing CY; Fan J; Zhou J; Qiu SJ
    J Surg Oncol; 2018 Jun; 117(7):1540-1547. PubMed ID: 29572833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT.
    Mulé S; Chalaye J; Legou F; Tenenhaus A; Calderaro J; Galletto Pregliasco A; Laurent A; Kharrat R; Amaddeo G; Regnault H; Tacher V; Kobeiter H; Itti E; Luciani A
    Eur Radiol; 2020 Oct; 30(10):5348-5357. PubMed ID: 32405753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic nomograms and risk classifications of outcomes in very early-stage hepatocellular carcinoma patients after hepatectomy.
    Feng LH; Sun HC; Zhu XD; Liu XF; Zhang SZ; Li XL; Li Y; Tang ZY
    Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):681-689. PubMed ID: 33189491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can IVIM help predict HCC recurrence after hepatectomy?
    Zhang Y; Kuang S; Shan Q; Rong D; Zhang Z; Yang H; Wu J; Chen J; He B; Deng Y; Roberts N; Shen J; Venkatesh SK; Wang J
    Eur Radiol; 2019 Nov; 29(11):5791-5803. PubMed ID: 30972544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma.
    Wang ZX; Jiang CP; Cao Y; Zhang G; Chen WB; Ding YT
    Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):178-85. PubMed ID: 25865691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early extrahepatic recurrence as a pivotal factor for survival after hepatocellular carcinoma resection: A 15-year observational study.
    Yoon JH; Choi SK; Cho SB; Kim HJ; Ko YS; Jun CH
    World J Gastroenterol; 2022 Sep; 28(36):5351-5363. PubMed ID: 36185633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1.
    Ruan DY; Lin ZX; Wang TT; Zhao H; Wu DH; Chen J; Dong M; Lin Q; Wu XY; Li Y
    Oncotarget; 2016 Sep; 7(38):61378-61389. PubMed ID: 27542216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Filamin A expression predicts early recurrence of hepatocellular carcinoma after hepatectomy.
    Donadon M; Di Tommaso L; Soldani C; Franceschini B; Terrone A; Mimmo A; Vitali E; Roncalli M; Lania A; Torzilli G
    Liver Int; 2018 Feb; 38(2):303-311. PubMed ID: 28727243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and validation of a clinical-radiomics model to predict recurrence for patients with hepatocellular carcinoma after curative resection.
    Ren Y; Bo L; Shen B; Yang J; Xu S; Shen W; Chen H; Wang X; Chen H; Cai X
    Med Phys; 2023 Feb; 50(2):778-790. PubMed ID: 36269204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The study of nomogram based on Ishak inflammation score for recurrence of hepatocellular carcinoma after curative resection].
    Luo XY; Du CY; Wei XF; Jiang N; Li M; Liao R
    Zhonghua Wai Ke Za Zhi; 2018 Feb; 56(2):124-129. PubMed ID: 29397626
    [No Abstract]   [Full Text] [Related]  

  • 32. Relationship between diffusion-weighted magnetic resonance imaging and histological tumor grading of hepatocellular carcinoma.
    Nakanishi M; Chuma M; Hige S; Omatsu T; Yokoo H; Nakanishi K; Kamiyama T; Kubota K; Haga H; Matsuno Y; Onodera Y; Kato M; Asaka M
    Ann Surg Oncol; 2012 Apr; 19(4):1302-9. PubMed ID: 21927976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The value of portal vein chemotherapy after radical resection in delaying intrahepatic recurrence of stage II primary hepatocellular carcinoma].
    Zhang GQ; Ge L; Ding W; Li HJ
    Ai Zheng; 2008 Dec; 27(12):1297-301. PubMed ID: 19079997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multi-institutional validation of novel models for predicting the prognosis of patients with huge hepatocellular carcinoma.
    Wang XH; Liu QB; Xiang CL; Mao XH; Yang B; Li Q; Zhou QF; Li SQ; Zhou ZG; Chen MS
    Int J Cancer; 2021 Jul; 149(1):127-138. PubMed ID: 33586134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative inflammation-based markers predict early and late recurrence of hepatocellular carcinoma after curative hepatectomy.
    Liu Y; Wang ZX; Cao Y; Zhang G; Chen WB; Jiang CP
    Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):266-74. PubMed ID: 27298102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Machine Learning Models for Prediction of Posttreatment Recurrence in Early-Stage Hepatocellular Carcinoma Using Pretreatment Clinical and MRI Features: A Proof-of-Concept Study.
    Iseke S; Zeevi T; Kucukkaya AS; Raju R; Gross M; Haider SP; Petukhova-Greenstein A; Kuhn TN; Lin M; Nowak M; Cooper K; Thomas E; Weber MA; Madoff DC; Staib L; Batra R; Chapiro J
    AJR Am J Roentgenol; 2023 Feb; 220(2):245-255. PubMed ID: 35975886
    [No Abstract]   [Full Text] [Related]  

  • 37. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
    Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
    BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T
    Wang WT; Zhu S; Ding Y; Yang L; Chen CZ; Ye QH; Ji Y; Zeng MS; Rao SX
    Eur J Radiol; 2018 Jun; 103():25-31. PubMed ID: 29803381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
    Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
    World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.